Jeffrey H. Murray

Array ( [id] => 5700687 [patent_doc_number] => 20060217372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Diaryl ethers as opioid receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/526960 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 150999 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217372.pdf [firstpage_image] =>[orig_patent_app_number] => 10526960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373476 [patent_doc_number] => 07473779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 10/662183 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26108 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473779.pdf [firstpage_image] =>[orig_patent_app_number] => 10662183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820017 [patent_doc_number] => 20060024330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/526275 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33550 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024330.pdf [firstpage_image] =>[orig_patent_app_number] => 10526275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 863873 [patent_doc_number] => 07368100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same' [patent_app_type] => utility [patent_app_number] => 10/525673 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14943 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368100.pdf [firstpage_image] =>[orig_patent_app_number] => 10525673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267197 [patent_doc_number] => 07566723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => '1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use' [patent_app_type] => utility [patent_app_number] => 10/527386 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12975 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566723.pdf [firstpage_image] =>[orig_patent_app_number] => 10527386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7398128 [patent_doc_number] => 20040038980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Imidazo-heterobicycles as factor xa inhibitors' [patent_app_type] => new [patent_app_number] => 10/641611 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35859 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038980.pdf [firstpage_image] =>[orig_patent_app_number] => 10641611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114831 [patent_doc_number] => 08158633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Phenyl-substituted pyrazolopyrimidines' [patent_app_type] => utility [patent_app_number] => 10/525115 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8223 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158633.pdf [firstpage_image] =>[orig_patent_app_number] => 10525115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875277 [patent_doc_number] => 20060166973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Organic compounds as agents for the treatment of aldosterone mediated conditions' [patent_app_type] => utility [patent_app_number] => 10/523870 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31980 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166973.pdf [firstpage_image] =>[orig_patent_app_number] => 10523870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748403 [patent_doc_number] => 20060111335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Photoactivated anti-viral and anti-cancer agent' [patent_app_type] => utility [patent_app_number] => 10/523315 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19017 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111335.pdf [firstpage_image] =>[orig_patent_app_number] => 10523315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285552 [patent_doc_number] => 07550479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Modified Pictet-Spengler reaction and products prepared therefrom' [patent_app_type] => utility [patent_app_number] => 10/521393 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4196 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550479.pdf [firstpage_image] =>[orig_patent_app_number] => 10521393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638103 [patent_doc_number] => 20060069077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Receptor-type kinase modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 10/522004 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77164 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069077.pdf [firstpage_image] =>[orig_patent_app_number] => 10522004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895471 [patent_doc_number] => 20060004010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Ccr4 antagonist and medical use thereof' [patent_app_type] => utility [patent_app_number] => 10/520660 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55826 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20060004010.pdf [firstpage_image] =>[orig_patent_app_number] => 10520660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7464086 [patent_doc_number] => 20040053331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Beta-strand mimetics and method relating thereto' [patent_app_type] => new [patent_app_number] => 10/449822 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29046 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053331.pdf [firstpage_image] =>[orig_patent_app_number] => 10449822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553574 [patent_doc_number] => 07820682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'LPA receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/530249 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63765 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820682.pdf [firstpage_image] =>[orig_patent_app_number] => 10530249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913672 [patent_doc_number] => 20060128734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases' [patent_app_type] => utility [patent_app_number] => 10/515113 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55582 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128734.pdf [firstpage_image] =>[orig_patent_app_number] => 10515113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553574 [patent_doc_number] => 07820682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'LPA receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/530249 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63765 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820682.pdf [firstpage_image] =>[orig_patent_app_number] => 10530249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851882 [patent_doc_number] => 20060235073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Diamino-functional chalcones' [patent_app_type] => utility [patent_app_number] => 10/514821 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47388 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235073.pdf [firstpage_image] =>[orig_patent_app_number] => 10514821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912898 [patent_doc_number] => 20050176656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => '4\"-Deoxy-4\"-(s)-amido avermectin derivatives' [patent_app_type] => utility [patent_app_number] => 10/513247 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18445 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176656.pdf [firstpage_image] =>[orig_patent_app_number] => 10513247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967179 [patent_doc_number] => 20050234076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Triazolopyrimidines' [patent_app_type] => utility [patent_app_number] => 10/511821 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8707 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234076.pdf [firstpage_image] =>[orig_patent_app_number] => 10511821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912942 [patent_doc_number] => 20050176700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => '7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension,cardiovascular or renal diseases' [patent_app_type] => utility [patent_app_number] => 10/513103 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122325 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176700.pdf [firstpage_image] =>[orig_patent_app_number] => 10513103 [rel_patent_id] =>[rel_patent_doc_number] =>)